« Previous
Next »
Titles
- Price increases for prescription drugs: 2016-20221
- Principles for selecting, developing, modifying, and adapting patient-reported outcome instruments for use in medical device evaluation: guidance for industry and Food and Drug Administration staff, and other stakeholders1
- Principles of premarket pathways for combination products: guidance for industry and FDA Staff1
- Prioritizing funding for public health initiatives in New York State1
- Private health insurance: Limited data hinders understanding of short-term plans’ role and value during the COVID-19 pandemic : report to congressional committees1
- Private health insurance: Markets remained concentrated through 2020, with increases in the individual and small group markets : report to congressional committees1
- Procedures for handling post-approval studies imposed by premarket approval application order: guidance for industry and Food and Drug Administration staff1
- Promoting readiness of minors in Supplemental Security Income (PROMISE). Youth and family outcomes five years after enrollment1
- Promoting readiness of minors in Supplemental Security Income (PROMISE). Youth’s pathways to education and employment1
- Providing regulatory submissions in electronic and non-electronic format: promotional labeling and advertising materials for human prescription drugs1
- Providing submissions in electronic format: postmarketing safety reports1
- Public health emergencies. Data management challenges impact national response1
- Public health preparedness: COVID-19 medical surge experiences and related HHS efforts : report to congressional addressees1
- Public health preparedness: HHS should address strategic national stockpile requirements and inventory risks : report to congressional addressees1
- Public health preparedness: Medical countermeasure development for certain serious or life-threatening conditions : report to congressional committees1
- Publicly insured and uninsured patients are more likely than other patients to be treated unfairly in health care settings because of their coverage type1